Do current indices predict cardioversion success in patients with atrial fibrillation? A retrospective observational study

Do current indices predict cardioversion success in patients with atrial fibrillation? A retrospective observational study

Atrial fibrillation (AF) is one of the leading arrhythmias that causes serious complications. Our aim is to investigate the factors predicting the success of cardioversion in patients who underwent the procedure due to AF.

Saved in:

Bibliographic Details
Main Authors:	Tatar Sefa, Yavuz Yunus Emre, Feyzullahoglu Emirhan, Sertdemir Ahmet Lütfi, Icli Abdullah, Akilli Hakan
Format:	Article
Language:	English
Published:	Sciendo 2025-03-01
Series:	Romanian Journal of Cardiology
Subjects:	atrial fibrillation leukoglycemic index fibrosis-4 index systemic immune-inflammation index cardioversion
Online Access:	https://doi.org/10.2478/rjc-2024-0028
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016-11-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019-01-01)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018-11-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

Takotsubo syndrome in a patient with atrial fibrillation after electrical cardioversion: a case report
by: E. S. Sitkova, et al.
Published: (2022-12-01)

Efficiency of Electrical Cardioversion of Paroxysmal Atrial Fibrillation in the Use of Bipolar QuasiSinusoidal Impulse in Patients with Coronary Heart Disease
by: V. A. Vostrikov, et al.
Published: (2014-06-01)

Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation
by: M. A. Zelberg, et al.
Published: (2024-05-01)

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
by: Yu. A. Bunin, et al.
Published: (2005-12-01)

Comparison of Angiotensin Converting Enzyme Inhibitors and Beta Blockers in Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion
by: Timuçin Altın, et al.
Published: (2007-12-01)

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
by: L. E. Kuvshinova, et al.
Published: (2015-09-01)

Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study
by: Arto Relander, et al.
Published: (2021-01-01)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
by: I. V. Graifer, et al.
Published: (2016-01-01)

Paroxysmal atrial fibrillation: treatment choice
by: B. A. Tatarsky
Published: (2007-06-01)

Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative?
by: I. A. Zaigraev, et al.
Published: (2023-05-01)

THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY
by: T. Y. Gromyko, et al.
Published: (2016-06-01)

The HALP Index Is Associated with the Recurrence of Persistent Atrial Fibrillation Following Radiofrequency Catheter Ablation
by: Wang Z, et al.
Published: (2025-04-01)

Propafenone efficacy and safety in restoring and maintaining sinus rhythm in patients with recurrent atrial fibrillation: results of the open, prospective placebo-controlled trial
by: I. G. Fomina, et al.
Published: (2005-04-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation
by: José Miguel Rivera-Caravaca, et al.
Published: (2025-07-01)

Pathogenic Mechanisms of Atrial Fibrillation in Obesity
by: O. M. Drapkina, et al.
Published: (2016-11-01)

Body roundness index, visceral adiposity index, and metabolic score for visceral fat in predicting new-onset atrial fibrillation: a UK Biobank cohort study
by: Yi ZHENG, et al.
Published: (2025-08-01)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)

2020 Clinical guidelines for Atrial fibrillation and atrial flutter
by: M. G. Arakelyan, et al.
Published: (2021-08-01)

Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment
by: Yu. A. Bunin, et al.
Published: (2018-09-01)

Retrospective analysis of the prevalence of ischemic stroke and the appointment of anticoagulant therapy in patients with atrial fibrillation depending on the body mass index
by: M. A. Druzhilov, et al.
Published: (2023-06-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2021-11-01)

Stroke risk assessment in patients with persistent atrial fibrillation to consider performing pre-cardioversion transesophageal echocardiography
by: E. S. Mazur, et al.
Published: (2021-11-01)

Glutathione peroxidase 4 as a potential biomarker for atrial fibrosis and recurrence of atrial fibrillation
by: Tong Liu, MD, et al.
Published: (2025-05-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2021-05-01)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
by: S. A. Zenin, et al.
Published: (2015-09-01)

Effect of catheter ablation for atrial fibrillation on left and right atrial function
by: T. V. Moskovskikh, et al.
Published: (2022-08-01)

Global myocardial work parameters measured by the index beat method are comparable to the average of 10 beats in patients during atrial fibrillation
by: Ling-Yun Kong, et al.
Published: (2025-08-01)

Active Compression During External Cardioversion of Atrial Fibrillation: A Meta‐Analysis of Randomized Controlled Trials
by: Hosam I. Taha, et al.
Published: (2025-05-01)

Association between triglyceride–glucose index and mortality in critically ill patients with atrial fibrillation: a retrospective cohort study
by: Rong Ding, et al.
Published: (2025-03-01)

Risk factors and nomogram prediction model for recurrence after radiofrequency ablation in patients with persistent atrial fibrillation
by: Shu-Cai Zhao, et al.
Published: (2025-08-01)

Electroanatomic substrate of atrial fibrillation in patients after COVID-19
by: An. M. Osadchy, et al.
Published: (2021-08-01)

Effect of atrial fibrosis on clot burden score and physicochemical properties of thrombus in patients with ischaemic stroke occurring in non-valvular atrial fibrillation
by: Juan Zhao, et al.
Published: (2025-03-01)

Validity of the questionnaires assessing quality of life in patients with non-valvular atrial fibrillation
by: E. V. Minakov, et al.
Published: (1970-01-01)